Delaware Bio to relocate to former AstraZeneca campus

449
Advertisement

Delle Donne and Associates (DDA) and Delaware Bio Association (Delaware Bio) announced that, effective in June, the organization currently located in Newark, will move its headquarters to the former AstraZeneca North Campus.

The site was acquired by Delle Donne in June 2017.

Ernest F. Delle Donne, chairman of DDA, said, “DDA is committed to supporting and growing Delaware’s emerging life sciences community. We have a similar project on 16 acres within the University of Delaware’s Science, Technology and Advanced Research Campus (STAR) in Newark. Through our work there, we have seen first-hand how necessary it is to surround high-tech and scientific start-ups with appropriate resources such as affordable lab and office space, educational services, professional mentoring, and other amenities. We believe the presence of Delaware Bio on our new property will serve as a great resource for these emerging, and typically fast-growing, life science businesses.”

Helen Stimson,  CEO of Delaware Bio, said, “As a connector organization, collaboration is critical to our success. Our decision to relocate to this new location supports our objective to work with multiple organizations, groups and individuals who share our focus on creating a cohesive and complete offering for bioscience start-ups.”

Stimson  continued, “In our new facility, we will have the ability and the space to offer more resources to our members including high-content educational seminars to support aspiring entrepreneurs, hot desks and conference rooms for emerging life science businesses, and a professional, centrally located place to network and evolve future alliances.”

Michael Bowman, associate director of the  Office of Economic Innovation and Partnerships at the University of Delaware, said, “Collaborative efforts are needed to ensure that young life science companies are properly supported and it is gratifying to see DDA and Delaware Bio combine forces to better support and accelerate growth within the biopharma sector.

“Importantly, Delaware Bio’s expanded headquarters will enable us to establish a satellite office within their new location and provide hands-on training for federal grant proposals, specifically SBIR and STTR programs, and much-needed business advisory services to support more efficient access to capital.”

 

In June of 2017, Delle Donne and Associates purchased the former AstraZeneca North Campus in Fairfax.

Advertisement

 AstraZeneca, the seller,  signed a long-term lease agreement for two buildings on the 80-acre campus. The campus is approved for another 900,000 square feet of development, and DDA additionally will be looking to add amenities that will help serve the surrounding 11,000  employees in the north Wilmington area.

The Delaware Bio 3,500 square foot facility is located on the campus entrance facing Concord Pike.

Advertisement
Advertisement